\-\ Texto\\:\\ \ \(0\)\
\-\ not\\ applicable\ \(4\)\
\-\ patient\\ is\\ unlikely\\ to\\ improve\\ with\\ continued\\ chemotherapy\\ and\\/or\\ radition\\ therapy\\.\\ \\ hospice\\ care\\ with\\ symptomatic\\ therapy\\ is\\ recommended\\.\ \(0\)\
\-\ chest\\ and\\ abdominal\\ ct\\ on\\ 13\\ april\\ 2006\\ revealed\\ the\\ following\\ in\\ comparison\\ with\\ an\\ august\\ 2004\\ chest\\ and\\ abdominal\\ ct\\:\ \(0\)\
\-\ \\ \\ \\â\\€\\¢\\ progression\\ of\\ right\\ hilar\\ adenopathy\\ and\\ enlargement\\ of\\ the\\ pleural\\-based\\ soft\\ tissue\\ mass\\ along\\ the\\ posteromedial\\ aspect\\ of\\ the\\ right\\ lower\\ lobe\\.\ \(0\)\
\-\ \\ \\ \\â\\€\\¢\\ pulmonary\\ parenchyma\\ demonstrates\\ enlargement\\ of\\ multiple\ \(0\)\
\-\ right\\ lower\\ lobe\\ pulmonary\\ nodules\\.\ \(1\)\
\-\ \\ \\ \\â\\€\\¢\\ \\ the\\ pancreas\\,\\ spleen\\,\\ adrenal\\ glands\\,\\ and\\ kidneys\\ are\\ normal\\.\\ \ \(0\)\
\-\ \\ \\ \\â\\€\\¢\\ \\ soft\\ tissue\\ in\\ the\\ bilateral\\ gluteal\\ regions\\ are\\ normal\\.\ \(0\)\
\-\ chest\\ and\\ abdomal\\ ct\\ on\\ 16\\ august\\ 2006\\ after\\ 4\\ months\\ of\\ chemotherapy\\ and\\ radiation\\ revealed\\ the\\ following\\ in\\ comparison\\ with\\ the\\ 13\\ april\\ 2006\\ study\\:\ \(0\)\
\-\ \\ \\ \\â\\€\\¢\\ \\ subcarinal\\ lymphadenopathy\\ is\\ demonstrated\\ and\\ increased\\ from\\ previous\\ study\\.\ \(0\)\
\-\ \\ \\ \\â\\€\\¢\\ \\ associated\\ rib\\ destruction\\ is\\ demonstrated\\.\ \(0\)\
\-\ \\ \\ \\â\\€\\¢\\ \\ associated\\ endobronchial\\ narrowing\\ is\\ demonstrated\\ extending\\ to\\ the\\ right\\ lower\\ lobe\\.\ \(0\)\
\-\ \\ \\ \\â\\€\\¢\\ \\ no\\ pulmonary\\ nodules\\ are\\ seen\\ in\\ the\\ left\\ lung\\.\ \(0\)\
\-\ \\ \\ \\â\\€\\¢\\ \\ interval\\ development\\ of\\ bilateral\\ adrenal\\ masses\\.\ \(0\)\
\-\ \\ \\ \\â\\€\\¢\\ \\ soft\\ tissue\\ masses\\ are\\ demonstrated\\ within\\ the\\ mesentery\\.\ \(0\)\
\-\ \\ \\ \\â\\€\\¢\\ \\ interval\\ development\\ of\\ right\\ gluteal\\ mass\ \(0\)\
\-\ metastatic\\ adenocarcinoma\\ of\\ the\\ lung\ \(0\)\
\-\ metastatic\\ adenocarcinoma\\ of\\ the\\ lung\ \(0\)\
\-\ metastatic\\ small\\ cell\\ cancer\\ of\\ the\\ lung\ \(0\)\
\-\ metastatic\\ squamous\\ cell\\ cancer\\ of\\ the\\ lung\ \(0\)\
\-\ other\\ metastatic\\ cancer\ \(0\)\
\-\ chief\\ complaint\\:\ \(0\)\
\-\ 47\\ y\\/o\\ male\\ presented\\ in\\ nov\\ 2005\\ with\\ pain\\ in\\ right\\ anterior\\ thigh\\.\\ \\ x\\-ray\\ revealed\\ a\\ mass\\ in\\ the\\ femur\\ and\\ adjacent\\ soft\\ tissue\\.\\ \\ partial\\ surgical\\ resection\\ of\\ mass\\ revealed\\ adenocarcinoma\\.\\ \\ subsequent\\ pet\\ scan\\ indicated\\ increased\\ uptake\\ at\\ several\\ locations\\ in\\ the\\ right\\ lung\\.\ \(0\)\
\-\ patient\\ had\\ a\\ history\\ of\\ pulmonary\\ nodules\\ dating\\ to\\ 2003\\/2004\\.\\ \\ however\\ a\\ pet\\ conducted\\ in\\ august\\ of\\ 2004\\ was\\ negative\\ except\\ for\\ minimal\\ uptake\\ in\\ one\\ pulmonary\\ nodule\\.\\ \\ serial\\ x\\-rays\\ showed\\ no\\ changes\\ in\\ these\\ nodules\\ through\\ mid\\ 2005\\.\ \(0\)\
\-\ patient\\ was\\ diagnosed\\ with\\ metastatic\\ adenocarcinoma\\ of\\ the\\ right\\ lung\\ and\\ referred\\ to\\ oncology\\ for\\ radiation\\ and\\ chemotherapy\\.\ \(0\)\
\-\ pmx\\:\ \(0\)\
\-\ \\ \\ \\â\\€\\¢\\ nephrolithiasis\ \(0\)\
\-\ \\ \\ \\â\\€\\¢\\ hyperlipidemia\ \(0\)\
\-\ pshx\\:\ \(0\)\
\-\ \\ \\ \\â\\€\\¢\\ right\\ neck\\ lymph\\ node\\ resection\\ \\(benign\\)\\ at\\ 22\\ yo\ \(0\)\
\-\ \\ \\ \\â\\€\\¢\\ cholestectomy\\ in\\ 2004\ \(0\)\
\-\ sochx\\:\ \(0\)\
\-\ \\ \\ \\â\\€\\¢\\ \\>1ppd\\ for\\ 20\\ years\ \(0\)\
\-\ \\ \\ \\â\\€\\¢\\ no\\ etoh\ \(0\)\
\-\ fmhx\\:\ \(0\)\
\-\ \\ \\ \\â\\€\\¢\\ sister\\ \\(smoker\\)\\ died\\ of\\ lung\\ cancer\\ in\\ 1979\ \(0\)\
\-\ \\ \\ \\â\\€\\¢\\ sister\\ \\(non\\-smoker\\)\\ died\\ of\\ lunger\\ cancer\\ at\\ 40\\ yo\ \(0\)\
\-\ \\ \\ \\â\\€\\¢\\ sister\\ \\(non\\-smoker\\)\\ died\\ of\\ lung\\ cancer\\ at\\ 62\\ yo\ \(0\)\
\-\ \\ \\ \\â\\€\\¢\\ brother\\ \\(smoker\\)\\ diagnosed\\ with\\ head\\ and\\ neck\\ cancer\\ 2006\ \(0\)\
\-\ meds\\:\ \(0\)\
\-\ \\ \\ \\â\\€\\¢\\ percocet\ \(0\)\
\-\ allergies\\:\ \(0\)\
\-\ \\ \\ \\â\\€\\¢\\ aspirin\\ \\-\\ upset\\ stomach\ \(0\)\
\-\ aggressive\\ spread\\ of\\ adenocarcinoma\\ of\\ the\\ lung\\ to\\ thoracic\\,\\ abdominal\\ and\\ soft\\ tissues\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.08044939751496745\ \(0\)\
\-\ lung\\:\\ 0\\.055249087505329156\ \(0\)\
\-\ 2006\\:\\ 0\\.043961590409427424\ \(0\)\
\-\ cancer\\:\\ 0\\.04389320725569946\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.04120038442592901\ \(0\)\
\-\ sister\\:\\ 0\\.039677321424578124\ \(0\)\
\-\ august\\:\\ 0\\.03522435510587333\ \(0\)\
\-\ died\\:\\ 0\\.03354144598792084\ \(0\)\
\-\ nodules\\:\\ 0\\.031629632726810276\ \(0\)\
\-\ 2004\\:\\ 0\\.030776857491899942\ \(0\)\
\-\ gluteal\\:\\ 0\\.029075595227555588\ \(0\)\
\-\ non\\-smoker\\:\\ 0\\.029075595227555588\ \(0\)\
\-\ metastatic\\:\\ 0\\.02880950094128692\ \(0\)\
\-\ pulmonary\\:\\ 0\\.027863284712277496\ \(0\)\
\-\ april\\:\\ 0\\.027265483137786997\ \(0\)\
\-\ revealed\\:\\ 0\\.024486374016661545\ \(0\)\
\-\ soft\\:\\ 0\\.023224629062428014\ \(0\)\
\-\ \\:\\:\\ 0\\.02270641371409818\ \(0\)\
\-\ smoker\\:\\ 0\\.02266896788251397\ \(0\)\
\-\ demonstrated\\:\\ 0\\.02238767841479435\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.02051079766835401\ \(0\)\
\-\ pet\\:\\ 0\\.02002136198071503\ \(0\)\
\-\ comparison\\:\\ 0\\.019848529337051234\ \(0\)\
\-\ radition\\:\\ 0\\.019677496482068076\ \(0\)\
\-\ abdomal\\:\\ 0\\.019677496482068076\ \(0\)\
\-\ 2003\\/2004\\:\\ 0\\.019677496482068076\ \(0\)\
\-\ pmx\\:\\ 0\\.019677496482068076\ \(0\)\
\-\ cholestectomy\\:\\ 0\\.019677496482068076\ \(0\)\
\-\ fmhx\\:\\ 0\\.019677496482068076\ \(0\)\
\-\ lunger\\:\\ 0\\.019677496482068076\ \(0\)\
\-\ adrenal\\:\\ 0\\.01931643774211767\ \(0\)\
\-\ interval\\:\\ 0\\.018707792904831367\ \(0\)\
\-\ pleural\\-based\\:\\ 0\\.018130292954032484\ \(0\)\
\-\ sochx\\:\\ 0\\.018130292954032484\ \(0\)\
\-\ upset\\:\\ 0\\.018130292954032484\ \(0\)\
\-\ right\\:\\ 0\\.018113137013378907\ \(0\)\
\-\ tissue\\:\\ 0\\.018084117754041014\ \(0\)\
\-\ 13\\:\\ 0\\.017230765028416237\ \(0\)\
\-\ hospice\\:\\ 0\\.01722523690914819\ \(0\)\
\-\ 1ppd\\:\\ 0\\.01722523690914819\ \(0\)\
\-\ yo\\:\\ 0\\.017218871807830993\ \(0\)\
\-\ development\\:\\ 0\\.016615036710534534\ \(0\)\
\-\ percocet\\:\\ 0\\.015678033381112594\ \(0\)\
\-\ lobe\\:\\ 0\\.015397267954845093\ \(0\)\
\-\ dating\\:\\ 0\\.015333947042212465\ \(0\)\
\-\ 2005\\.\\:\\ 0\\.015333947042212465\ \(0\)\
\-\ 1979\\:\\ 0\\.015333947042212465\ \(0\)\
\-\ uptake\\:\\ 0\\.01515617600309916\ \(0\)\
\-\ enlargement\\:\\ 0\\.01513646610037989\ \(0\)\
\-\ abdominal\\:\\ 0\\.014303030612424878\ \(0\)\
\-\ subcarinal\\:\\ 0\\.014130829853077002\ \(0\)\
\-\ pshx\\:\\ 0\\.014130829853077002\ \(0\)\
\-\ diagnosed\\:\\ 0\\.014027656949977702\ \(0\)\
\-\ brother\\:\\ 0\\.013786743514176874\ \(0\)\
\-\ chest\\:\\ 0\\.01369238169681374\ \(0\)\
\-\ endobronchial\\:\\ 0\\.013488682369925706\ \(0\)\
\-\ nov\\:\\ 0\\.013488682369925706\ \(0\)\
\-\ posteromedial\\:\\ 0\\.012990594085742203\ \(0\)\
\-\ masses\\:\\ 0\\.012895501776768245\ \(0\)\
\-\ lower\\:\\ 0\\.012869612071633008\ \(0\)\
\-\ applicable\\:\\ 0\\.012583626325041411\ \(0\)\
\-\ conducted\\:\\ 0\\.012583626325041411\ \(0\)\
\-\ study\\:\\ 0\\.012551925700267674\ \(0\)\
\-\ radiation\\:\\ 0\\.012518978792689001\ \(0\)\
\-\ etoh\\:\\ 0\\.012492505801558699\ \(0\)\
\-\ aspirin\\:\\ 0\\.012492505801558699\ \(0\)\
\-\ in\\:\\ 0\\.012228044624605612\ \(0\)\
\-\ oncology\\:\\ 0\\.012161211147276838\ \(0\)\
\-\ resection\\:\\ 0\\.011896944890715262\ \(0\)\
\-\ hyperlipidemia\\:\\ 0\\.011806156025335572\ \(0\)\
\-\ meds\\:\\ 0\\.011741451701957777\ \(0\)\
\-\ mesentery\\:\\ 0\\.011678570280157115\ \(0\)\
\-\ x\\-rays\\:\\ 0\\.011557884518393107\ \(0\)\
\-\ glands\\:\\ 0\\.011334483941256985\ \(0\)\
\-\ chief\\:\\ 0\\.011281960509537801\ \(0\)\
\-\ nephrolithiasis\\:\\ 0\\.011230644620643385\ \(0\)\
\-\ neck\\:\\ 0\\.011201978290261082\ \(0\)\
\-\ allergies\\:\\ 0\\.011180481995973612\ \(0\)\
\-\ locations\\:\\ 0\\.011131421936333489\ \(0\)\
\-\ following\\:\\ 0\\.010827132843308697\ \(0\)\
\-\ mass\\:\\ 0\\.010611258990603254\ \(0\)\
\-\ thigh\\:\\ 0\\.010429427896372691\ \(0\)\
\-\ 62\\:\\ 0\\.010429427896372691\ \(0\)\
\-\ are\\:\\ 0\\.010400659576157158\ \(0\)\
\-\ at\\:\\ 0\\.010337171007425294\ \(0\)\
\-\ cell\\:\\ 0\\.01030464603384592\ \(0\)\
\-\ 2005\\:\\ 0\\.010292021885213241\ \(0\)\
\-\ spleen\\:\\ 0\\.01025895249729998\ \(0\)\
\-\ therapy\\:\\ 0\\.010199289268931308\ \(0\)\
\-\ improve\\:\\ 0\\.010162586042243711\ \(0\)\
\-\ 47\\:\\ 0\\.010010680990357516\ \(0\)\
\-\ pancreas\\:\\ 0\\.009760864213116477\ \(0\)\
\-\ except\\:\\ 0\\.009658218871058836\ \(0\)\
\-\ hilar\\:\\ 0\\.009584218408297896\ \(0\)\
\-\ rib\\:\\ 0\\.009536213485929675\ \(0\)\
\-\ serial\\:\\ 0\\.009512592706174012\ \(0\)\
\-\ progression\\:\\ 0\\.009489219268970228\ \(0\)\
\-\ destruction\\:\\ 0\\.009420532530874796\ \(0\)\
\-\ increased\\:\\ 0\\.009332521347319891\ \(0\)\
\-\ squamous\\:\\ 0\\.009332119276198354\ \(0\)\
\-\ aggressive\\:\\ 0\\.009332119276198354\ \(0\)\
\-\ bilateral\\:\\ 0\\.00925811486301091\ \(0\)\
\-\ spread\\:\\ 0\\.009226310707237229\ \(0\)\
\-\ unlikely\\:\\ 0\\.009086130124114392\ \(0\)\
\-\ associated\\:\\ 0\\.009002065008516526\ \(0\)\
\-\ complaint\\:\\ 0\\.008812464226586865\ \(0\)\
\-\ kidneys\\:\\ 0\\.008778385047723498\ \(0\)\
\-\ regions\\:\\ 0\\.008728222423053725\ \(0\)\
\-\ node\\:\\ 0\\.008728222423053725\ \(0\)\
\-\ 16\\:\\ 0\\.00863115744104538\ \(0\)\
\-\ x\\-ray\\:\\ 0\\.00859971828952364\ \(0\)\
\-\ 22\\:\\ 0\\.008507973477725533\ \(0\)\
\-\ adenopathy\\:\\ 0\\.008493042700603219\ \(0\)\
\-\ stomach\\:\\ 0\\.008434298708823368\ \(0\)\
\-\ indicated\\:\\ 0\\.008253403150780677\ \(0\)\
\-\ femur\\:\\ 0\\.0082400768851858\ \(0\)\
\-\ continued\\:\\ 0\\.008213660685080884\ \(0\)\
\-\ parenchyma\\:\\ 0\\.008123590829001492\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.008111015343023243\ \(0\)\
\-\ \\(\\:\\ 0\\.008062072837543087\ \(0\)\
\-\ and\\/or\\:\\ 0\\.008061410126985942\ \(0\)\
\-\ 40\\:\\ 0\\.008024916515375386\ \(0\)\
\-\ ct\\:\\ 0\\.00800426553610743\ \(0\)\
\-\ mid\\:\\ 0\\.007977168323452802\ \(0\)\
\-\ \\)\\:\\ 0\\.007963590313764566\ \(0\)\
\-\ recommended\\:\\ 0\\.007907408181702569\ \(0\)\
\-\ nodule\\:\\ 0\\.007862083926879477\ \(0\)\
\-\ tissues\\:\\ 0\\.007828684657511815\ \(0\)\
\-\ lymph\\:\\ 0\\.0076998714485371576\ \(0\)\
\-\ narrowing\\:\\ 0\\.007648318513727673\ \(0\)\
\-\ partial\\:\\ 0\\.007628026166180235\ \(0\)\
\-\ symptomatic\\:\\ 0\\.00757808800154958\ \(0\)\
\-\ minimal\\:\\ 0\\.007509999933930351\ \(0\)\
\-\ subsequent\\:\\ 0\\.007425403343325472\ \(0\)\
\-\ previous\\:\\ 0\\.007407031693467178\ \(0\)\
\-\ thoracic\\:\\ 0\\.007352806933268419\ \(0\)\
\-\ referred\\:\\ 0\\.007197614829142056\ \(0\)\
\-\ care\\:\\ 0\\.006879859703278465\ \(0\)\
\-\ 20\\:\\ 0\\.0068582929378504815\ \(0\)\
\-\ benign\\:\\ 0\\.006582701712127681\ \(0\)\
\-\ extending\\:\\ 0\\.0064123193054459755\ \(0\)\
\-\ \\>\\:\\ 0\\.006337427488099474\ \(0\)\
\-\ along\\:\\ 0\\.006303691689416331\ \(0\)\
\-\ is\\:\\ 0\\.006275566723043813\ \(0\)\
\-\ showed\\:\\ 0\\.006254025151615394\ \(0\)\
\-\ several\\:\\ 0\\.006131903651166043\ \(0\)\
\-\ adjacent\\:\\ 0\\.006030884473513989\ \(0\)\
\-\ aspect\\:\\ 0\\.005991723068043208\ \(0\)\
\-\ normal\\:\\ 0\\.005980412743745987\ \(0\)\
\-\ the\\:\\ 0\\.005863250913769844\ \(0\)\
\-\ no\\:\\ 0\\.00576190279489153\ \(0\)\
\-\ patient\\:\\ 0\\.005736106680243669\ \(0\)\
\-\ negative\\:\\ 0\\.005696696788783201\ \(0\)\
\-\ years\\:\\ 0\\.005600989145130541\ \(0\)\
\-\ changes\\:\\ 0\\.0054666249469532595\ \(0\)\
\-\ through\\:\\ 0\\.005417314773260867\ \(0\)\
\-\ head\\:\\ 0\\.005409824353959589\ \(0\)\
\-\ scan\\:\\ 0\\.005339891652752184\ \(0\)\
\-\ 4\\:\\ 0\\.005314669431203226\ \(0\)\
\-\ however\\:\\ 0\\.005311089409814889\ \(0\)\
\-\ y\\/o\\:\\ 0\\.00528265408441884\ \(0\)\
\-\ months\\:\\ 0\\.005209690389933186\ \(0\)\
\-\ of\\:\\ 0\\.005201062535624483\ \(0\)\
\-\ presented\\:\\ 0\\.005199459006746449\ \(0\)\
\-\ one\\:\\ 0\\.005169043266318402\ \(0\)\
\-\ these\\:\\ 0\\.00496393904454875\ \(0\)\
\-\ anterior\\:\\ 0\\.004912483981613253\ \(0\)\
\-\ for\\:\\ 0\\.004882420638232467\ \(0\)\
\-\ and\\:\\ 0\\.004821669796398708\ \(0\)\
\-\ to\\:\\ 0\\.0047663851388726145\ \(0\)\
\-\ was\\:\\ 0\\.0044119532241682444\ \(0\)\
\-\ other\\:\\ 0\\.004396514617639394\ \(0\)\
\-\ small\\:\\ 0\\.004394141259779282\ \(0\)\
\-\ demonstrates\\:\\ 0\\.004166565182261575\ \(0\)\
\-\ had\\:\\ 0\\.0041157362036622945\ \(0\)\
\-\ \\-\\:\\ 0\\.0040886795953311685\ \(0\)\
\-\ multiple\\:\\ 0\\.004017424114909082\ \(0\)\
\-\ surgical\\:\\ 0\\.00400942359431128\ \(0\)\
\-\ after\\:\\ 0\\.003946431255824112\ \(0\)\
\-\ seen\\:\\ 0\\.0037692580693475227\ \(0\)\
\-\ within\\:\\ 0\\.0036386861794332178\ \(0\)\
\-\ male\\:\\ 0\\.0034491195042131097\ \(0\)\
\-\ on\\:\\ 0\\.003231656305202804\ \(0\)\
\-\ from\\:\\ 0\\.002826865431147795\ \(0\)\
\-\ not\\:\\ 0\\.0027562916779953913\ \(0\)\
\-\ a\\:\\ 0\\.0026558022443209906\ \(0\)\
\-\ an\\:\\ 0\\.002637644786349843\ \(0\)\
\-\ history\\:\\ 0\\.0026344074502390254\ \(0\)\
\-\ \\,\\:\\ 0\\.0024170541564043514\ \(0\)\
\-\ pain\\:\\ 0\\.0023294825168096757\ \(0\)\
\-\ left\\:\\ 0\\.0021341635474841844\ \(0\)\
\-\ with\\:\\ 0\\.0018281902514045271\ \(0\)\
\-\ \\.\\:\\ 0\\.00158480071863153\ \(0\)\
